×

Home | Capabilities | Case Studies

SecurAcath

Department/BU : Medical
Territory : UK

SUMMARY
NICE Guidelines state: Annual savings across the NHS in England from using SecurAcath are estimated to be a minimum of 4.2 million.

THE CHALLENGE

The challenge in Vascular access arena with regards to PICC lines and competitor products include:
- rates of catheter migration and dislodgement
- rates of catheter-related infection, including catheter-related bloodstream infection,
- local infection or inflammation and thrombophlebitis
- number of unplanned catheter removals and reinsertions

Need to change practice for Clinical Staff with a training and support given by Aquilant Medical.

Converting all UK Trust using SecurAcath in PICC/MID/Central Lines and moving into Interventional Radiology and feeding tubes.

THE APPROACH

Identifying the clinicians, understanding their issues and gaining acknowledgement of the accurate rates around dislodgment rates.

Introducing the product, agreeing a defined patient group for the trial and training all areas of the hospital.

Arranging clinical trials amongst Oncology & Haematology patients with agreement from Procurement and Infection Control teams.

Setting up training with PICC Nurses
Inserting PICC Lines through to follow up of care & maintenance.
Other sessions of training on all Wards & Units plus community teams.

With approximately a third of UK Trusts using SecurAcath.

THE RESULTS

Successful implementation of the sales/training programme and improved customer relationship has enable Aquilant Medical to reach a wider segmented target audience.

Developed a strong KOL base within the UK and leveraged expertise.

Dramatically Reduced Catheter Dislodgement. 0 - 1.5% vs Adhesive Securement rates of 14 - 20%

Increased sales revenue since 2016.